Insider Trading & Ownership - Kazam Joshua A

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kazam Joshua A
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-12
Purchase
2022-01-14
2:13 pm
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
15,000$12.6$189,000258,885
(Direct)
View
2021-02-12
Purchase
2021-02-16
6:03 pm
Tishman Speyer Innovation Corp. IITSIBKazam Joshua A
Director
25,000$0$030,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-25
Option Award
2024-06-26
4:32 pm
N/A
2034-06-24
Kronos Bio Inc.KRONKazam Joshua A
Director
34,000$034,000
(Direct)
View
2024-06-05
Option Award
2024-06-07
5:28 pm
N/A
2034-06-05
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
191,082$0191,082
(Direct)
View
2023-06-22
Option Award
2023-06-26
4:09 pm
N/A
2033-06-21
Kronos Bio Inc.KRONKazam Joshua A
Director
34,000$034,000
(Direct)
View
2023-06-13
Option Award
2023-06-15
4:56 pm
N/A
2033-06-13
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
116,120$0116,120
(Direct)
View
2022-06-22
Option Award
2022-06-29
4:08 pm
N/A
2032-06-21
Kronos Bio Inc.KRONKazam Joshua A
Director
34,000$034,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:58 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
44,178$0303,063
(Direct)
View
2022-03-07
Other
2022-03-09
6:26 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
412,618$0671,503
(Direct)
View
2022-03-07
Gift
2022-03-09
6:26 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
412,618$0671,503
(Direct)
View
2022-03-07
Gift
2022-03-09
4:40 pm
N/A
N/A
Kronos Bio Inc.KRONKazam Joshua A
Director
211,000$094,481
(Direct)
View
2021-06-22
Option Award
2021-06-23
9:16 pm
N/A
2031-06-21
Kronos Bio Inc.KRONKazam Joshua A
Director
20,600$020,600
(Direct)
View
2021-06-11
Gift
2021-06-11
5:43 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
500,000$0243,885
(Direct)
View
2021-06-10
Option Award
2021-06-11
5:43 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
16,498$0243,885
(Direct)
View
2021-06-04
Exercise
2021-06-07
6:39 pm
N/A
N/A
TS Innovation Acquisitions Corp.LTCHKazam Joshua A
Former Director
Director
30,000$030,000
(Direct)
View

Ownership
2021-02-11
8:27 pm
N/A
N/A
Tishman Speyer Innovation Corp. IITSIBKazam Joshua A
Director
0$030,000
(Direct)
View
2020-10-21
Ownership
2021-02-03
4:22 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
305,918$0727,387
(Direct)
View

Ownership
2020-11-09
6:44 pm
N/A
N/A
TS Innovation Acquisitions Corp.TSIAKazam Joshua A
Director
0$030,000
(Direct)
View
2020-10-14
Conversion
2020-10-16
3:47 pm
N/A
N/A
Kronos Bio Inc.KRONKazam Joshua A
Director
179,927$094,481
(Direct)
View

Ownership
2020-10-08
7:09 pm
N/A
N/A
Kronos Bio Inc.KRONKazam Joshua A
Director
0$094,481
(Direct)
View
2020-06-05
Option Award
2020-06-09
4:04 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
9,969$01,033,305
(Direct)
View
2020-04-24
Other
2020-04-28
4:33 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
8,039$01,031,375
(Direct)
View
2020-03-04
Other
2020-03-11
4:39 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
8,217$01,023,514
(Direct)
View

Ownership
2020-03-05
5:08 pm
N/A
N/A
Flying Eagle Acquisition Corp.FEACKazam Joshua A
Director
0$020,000
(Direct)
View
2019-12-31
Other
2019-12-31
6:38 pm
N/A
N/A
Diamond Eagle Acquisition Corp.DEACKazam Joshua A
Director
20,000$0.000120,000
(Direct)
View